BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  NanoBio Corporation Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan

  April 21, 2011

   · 

  1 min read
• Memorandum of Understanding Between ARG Vermögensverwaltung AG and Compass Biotechnologies Inc. for up to a $10 Million Financing

  April 21, 2011

   · 

  4 min read
• Pharm Country

  Novo Nordisk A/S Announces U.S. Launch of NovoTwist(R) for Use with Levemir(R) FlexPen(R), NovoLog(R) FlexPen(R) and Victoza(R) Pen Devices

  April 21, 2011

   · 

  8 min read
• Job Trends

  Construction Begins at Worcester Polytechnic Institute/Gateway Park, Creating 140 Stable Jobs

  April 21, 2011

   · 

  8 min read
• Deals

  Hanmi Pharmaceutical, Co., Ltd to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories

  April 21, 2011

   · 

  4 min read
• Drug Development

  FDA Grants Orphan Drug Designation For Nektar Therapeutics (AL)'s Investigational Drug (NKTR)

  April 21, 2011

   · 

  6 min read
• FDA

  Lexington International, LLC’s HairMax Achieves New Milestones in Hair Growth with Statistically Significant Clinical Studies and FDA Clearance

  April 21, 2011

   · 

  3 min read
• Drug Development

  Tekmira Pharmaceuticals Corporation and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target

  April 21, 2011

   · 

  1 min read
• Biotech Bay

  Five-Nation Breast Cancer Study Chooses Agilent Technologies Inc. Microarrays as Primary Genomic Screening Tool

  April 21, 2011

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases

  April 21, 2011

   · 

  8 min read